Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in YouthRajen Mody, Arul M. Chinnaiyan, Andrew C. Harris et al.|JAMA|2015Cited by 420
ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and DeathMark T. Vander Lugt, Sophie Paczesny, Thomas Braun et al.|New England Journal of Medicine|2013Cited by 403
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host diseaseJames L.M. Ferrara, Sophie Paczesny, Andrew C. Harris et al.|Blood|2011Cited by 331
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHDBenjamin Watkins, Leslie S. Kean, Muna Qayed et al.|Journal of Clinical Oncology|2021Cited by 255
Plasma biomarkers of lower gastrointestinal and liver acute GVHDAndrew C. Harris, Sophie Paczesny, James L.M. Ferrara et al.|Blood|2012Cited by 144